From the Journals

COVID vs. flu: Which is deadlier?


 

FROM JAMA NETWORK OPEN

COVID-19 remains deadlier than influenza in severe cases requiring hospitalization, a new study shows.

People who were hospitalized with Omicron COVID-19 infections were 54% more likely to die, compared with people who were hospitalized with the flu, Swiss researchers found.

The results of the study continue to debunk an earlier belief from the start of the pandemic that the flu was the more dangerous of the two respiratory viruses. The researchers noted that the deadliness of COVID-19, compared with flu, persisted “despite virus evolution and improved management strategies.”

The study was published in JAMA Network Open and included 5,212 patients in Switzerland hospitalized with COVID-19 or the flu. All the COVID patients were infected with the Omicron variant and hospitalized between Jan. 15, 2022, and March 15, 2022. Flu data included cases from January 2018 to March 15, 2022.

Overall, 7% of COVID-19 patients died, compared with 4.4% of flu patients. Researchers noted that the death rate for hospitalized COVID patients had declined since their previous study, which was conducted during the first COVID wave in the first half of 2020. At that time, the death rate of hospitalized COVID patients was 12.8%.

Since then, 98% of the Swiss population has been vaccinated. “Vaccination still plays a significant role regarding the main outcome,” the authors concluded, since a secondary analysis in this most recent study showed that unvaccinated COVID patients were twice as likely to die, compared with flu patients.

“Our results demonstrate that COVID-19 still cannot simply be compared with influenza,” they wrote.

While the death rate among COVID patients was significantly higher, there was no difference in the rate that COVID or flu patients were admitted to the ICU, which was around 8%.

A limitation of the study was that all the COVID cases did not have laboratory testing to confirm the Omicron variant. However, the study authors noted that Omicron accounted for at least 95% of cases during the time the patients were hospitalized. The authors were confident that their results were not biased by the potential for other variants being included in the data.

Four coauthors reported receiving grants and personal fees from various sources.

A version of this article first appeared on WebMD.com.

Recommended Reading

Must-read acute care medicine articles from 2022
MDedge Infectious Disease
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
MDedge Infectious Disease
Prehospital COVID therapy effective in rheumatic disease patients
MDedge Infectious Disease
New challenge for docs: End of COVID federal public health emergency
MDedge Infectious Disease
Cardiac issues twice as likely with COVID plus high troponin
MDedge Infectious Disease
COVID-19 shot appears to reduce diabetes risk, even after Omicron
MDedge Infectious Disease
What’s new in brain health?
MDedge Infectious Disease
Untreated COVID often involves relapse, clarifying antiviral rebound discussion
MDedge Infectious Disease
COVID infection provides immunity equal to vaccination: Study
MDedge Infectious Disease
Pfizer COVID vaccine effective in young children, study shows
MDedge Infectious Disease